Fibromyalgia Trial, Recruiting (NCT06487741)

Fibromyalgia Trial, Recruiting NCT06487741 Sponsor: University College of Northern Denmark Condition: Fibromyalgia

Printed from Voxsanity (voxsanity.com.au) — NCT06487741 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Fibromyalgia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with fibromyalgia based on the 2016 American College of Rheumatology guidelines
You have been diagnosed with long-term (chronic) pain that is not caused by cancer, or widespread long-term pain across your body, as long as you also meet the fibromyalgia diagnostic guidelines mentioned above

Who may not be able to join:

You have a systemic (whole-body) condition such as high blood pressure, diabetes, or heart problems that is not well controlled by current treatment
You have a neurological condition (a condition affecting the brain or nerves) that affects your ability to stay alert or understand information
You have a muscle or joint condition that could affect the study's tests and measurements, such as a trapped nerve or knee joint inflammation
You have a significant joint disorder, such as severe arthritis, a hip or knee replacement, or rheumatoid arthritis
Your fibromyalgia treatment or medications have been changed within the last four weeks before the start of the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lise Eckardt, Pt. Msc, Department of Physiotherapy, University College of Northern Denmark

Phone: 72691004

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06487741

Sponsor: University College of Northern Denmark

Phase: Not Applicable

Status: Recruiting

Condition: Fibromyalgia

Trial contact: 72691004

More information: https://clinicaltrials.gov/study/NCT06487741

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with fibromyalgia based on the 2016 American College of Rheumatology guidelines
You have been diagnosed with long-term (chronic) pain that is not caused by cancer, or widespread long-term pain across your body, as long as you also meet the fibromyalgia diagnostic guidelines mentioned above

Who may not be able to join:

You have a systemic (whole-body) condition such as high blood pressure, diabetes, or heart problems that is not well controlled by current treatment
You have a neurological condition (a condition affecting the brain or nerves) that affects your ability to stay alert or understand information
You have a muscle or joint condition that could affect the study's tests and measurements, such as a trapped nerve or knee joint inflammation
You have a significant joint disorder, such as severe arthritis, a hip or knee replacement, or rheumatoid arthritis
Your fibromyalgia treatment or medications have been changed within the last four weeks before the start of the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University College of Northern Denmark

Registry

ClinicalTrials.gov

Start date

31 October 2024

Est. completion

30 August 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Severity of symptoms; Severity of symptoms; Severity of symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov